Anne S. De Groot M.D. has been CEO of EpiVax since founding the company in 1998 (27 years). In 2025, she will step back into the CMO position. She retains her position as CEO and co-founder of EpiVax Therapeutics, a translational biotechnology company that is a subsidiary of EpiVax, Inc. She earned an MD at the University of Chicago Pritzker School of Medicine (1983). She was formerly Professor (Research) and Senior Scientist at the University of Georgia from 2020 to 2023, Director of the Institute for Immunology and Informatics at the University of Rhode Island from 2009 to 2019, and faculty at the Brown University School of Medicine from 1993-2008. She is one of the founders and was the Volunteer Medical Director of Clinica Esperanza from 2008 to 2023, and remains on the Board of Directors. She was also founder and intermittently serves as Executive Director and/or Scientific Director of GAIA Vaccine Foundation from 2003 until the present. Her research interests include cellular immunology, vaccines, T lymphocytes, and immunology of infectious diseases, as well as public health, vaccine acceptance, and immunogenicity in general.
Anne S. De Groot M.D. has been CEO of EpiVax since founding the company in 1998 (27 years). In 2025, she will step back into the CMO position. She retains her position as CEO and co-founder of EpiVax Therapeutics, a translational biotechnology company that is a subsidiary of EpiVax, Inc. She earned an MD at the University of Chicago Pritzker School of Medicine (1983). She was formerly Professor (Research) and Senior Scientist at the University of Georgia from 2020 to 2023, Director of the Institute for Immunology and Informatics at the University of Rhode Island from 2009 to 2019, and faculty at the Brown University School of Medicine from 1993-2008. She is one of the founders and was the Volunteer Medical Director of Clinica Esperanza from 2008 to 2023, and remains on the Board of Directors. She was also founder and intermittently serves as Executive Director and/or Scientific Director of GAIA Vaccine Foundation from 2003 until the present. Her research interests include cellular immunology, vaccines, T lymphocytes, and immunology of infectious diseases, as well as public health, vaccine acceptance, and immunogenicity in general.